久久久久一级片-国产69久久精品成人看-欧美日韩精品一区二区三区-日韩精品午夜

當前位置:產品中心 > 抗體 > Biosimilar抗體 > Anti-H_SLC39A6 hIgG1 Antibody(Ladiratuzumab)
Anti-H_SLC39A6 hIgG1 Antibody(Ladiratuzumab)
基本信息

產品編號:GM-26839AB

產品名稱:Anti-H_SLC39A6 hIgG1 Antibody(Ladiratuzumab)

目錄價:詢價


/ueditor/image/20240515/1715738958657039/078b2aef53b4f29152b223ad7c4e2089.jpg

規格貨號

GM-26839AB-10           10 μg

GM-26839AB-100         100 μg

GM-26839AB-1000       1mg

產品簡介

Species Reactivity      Human; Cynomolgus

Clone                           Ladiratuzumab

Source/Isotype           Monoclonal human IgG1, κ

Application                 Flow Cytometry

Specificity                   Detects SLC39A6

Gene                            SLC39A6

Other Names              LIV-1; LIV1; ZIP6

Gene ID                       25800(human), 101926643(cynomolgus)

Background                SLC39A6 is also known as LIV-1, ZIP-6 and Zinc transporter ZIP6. May act as a zinc-influx transporter. Highly expressed in the breast, prostate, placenta, kidney, pituitary, and corpus callosum. Weakly expressed in heart and intestine. Also highly expressed in cells derived from an adenocarcinoma of the cervix and lung carcinoma. The LIV-1 protein has also been implicated in certain cancerous conditions, e.g., breast cancer and prostate cancer. The detection of LIV-1 is associated with estrogen receptor-positive breast cancer, and the metastatic spread of these cancers to the regional lymph nodes. 

Storage                        Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.

Formulation                Phosphate-buffered solution, pH 7.2.

Endotoxin                    < 1 EU/mg, determined by LAL gel clotting assay

數據展示

/ueditor/image/20240515/1715739100567930/4997566fa52c418dd7b4ff95007aceb1.png

/ueditor/image/20240515/1715739117284180/6615bd397476aee8f7175814e6e8f631.png

當前位置:產品中心 > 抗體 > Biosimilar抗體 > Anti-H_SLC39A6 hIgG1 Antibody(Ladiratuzumab)

Anti-H_SLC39A6 hIgG1 Antibody(Ladiratuzumab)
基本信息

產品編號:GM-26839AB

產品名稱:Anti-H_SLC39A6 hIgG1 Antibody(Ladiratuzumab)

目錄價:詢價


/ueditor/image/20240515/1715738958657039/078b2aef53b4f29152b223ad7c4e2089.jpg

規格貨號

GM-26839AB-10           10 μg

GM-26839AB-100         100 μg

GM-26839AB-1000       1mg

產品簡介

Species Reactivity      Human; Cynomolgus

Clone                           Ladiratuzumab

Source/Isotype           Monoclonal human IgG1, κ

Application                 Flow Cytometry

Specificity                   Detects SLC39A6

Gene                            SLC39A6

Other Names              LIV-1; LIV1; ZIP6

Gene ID                       25800(human), 101926643(cynomolgus)

Background                SLC39A6 is also known as LIV-1, ZIP-6 and Zinc transporter ZIP6. May act as a zinc-influx transporter. Highly expressed in the breast, prostate, placenta, kidney, pituitary, and corpus callosum. Weakly expressed in heart and intestine. Also highly expressed in cells derived from an adenocarcinoma of the cervix and lung carcinoma. The LIV-1 protein has also been implicated in certain cancerous conditions, e.g., breast cancer and prostate cancer. The detection of LIV-1 is associated with estrogen receptor-positive breast cancer, and the metastatic spread of these cancers to the regional lymph nodes. 

Storage                        Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.

Formulation                Phosphate-buffered solution, pH 7.2.

Endotoxin                    < 1 EU/mg, determined by LAL gel clotting assay

數據展示

/ueditor/image/20240515/1715739100567930/4997566fa52c418dd7b4ff95007aceb1.png

/ueditor/image/20240515/1715739117284180/6615bd397476aee8f7175814e6e8f631.png

Tel: 400-627-9288
留言咨詢
重置
提交
客服
微信
電話
留言
留言咨詢
重置
提交